Limei Zhao

4.0k total citations
129 papers, 3.0k citations indexed

About

Limei Zhao is a scholar working on Pediatrics, Perinatology and Child Health, Oncology and Psychiatry and Mental health. According to data from OpenAlex, Limei Zhao has authored 129 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Pediatrics, Perinatology and Child Health, 31 papers in Oncology and 27 papers in Psychiatry and Mental health. Recurrent topics in Limei Zhao's work include Pharmacological Effects and Toxicity Studies (33 papers), Drug Transport and Resistance Mechanisms (23 papers) and Epilepsy research and treatment (22 papers). Limei Zhao is often cited by papers focused on Pharmacological Effects and Toxicity Studies (33 papers), Drug Transport and Resistance Mechanisms (23 papers) and Epilepsy research and treatment (22 papers). Limei Zhao collaborates with scholars based in China, United States and New Zealand. Limei Zhao's co-authors include Junwei Ye, Guofei Li, Mingming Zhao, Raji Feyisa Bogale, Feng Qiu, Kai Yuan, Jie Tian, Wei Qin, Karen M. von Deneen and Dahua Yu and has published in prestigious journals such as PLoS ONE, Analytical Chemistry and Scientific Reports.

In The Last Decade

Limei Zhao

123 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Limei Zhao China 29 772 497 493 483 344 129 3.0k
Masataka Yokoyama Japan 44 177 0.2× 184 0.4× 293 0.6× 453 0.9× 393 1.1× 313 7.5k
Ting Bao United States 41 149 0.2× 241 0.5× 977 2.0× 242 0.5× 217 0.6× 178 5.3k
Shengying Qin China 26 265 0.3× 169 0.3× 226 0.5× 120 0.2× 276 0.8× 163 3.0k
Caroline M. Spencer New Zealand 39 415 0.5× 194 0.4× 96 0.2× 71 0.1× 587 1.7× 88 4.7k
Krishna K. Sharma India 33 169 0.2× 136 0.3× 923 1.9× 223 0.5× 179 0.5× 101 3.2k
Wen Liu China 42 175 0.2× 63 0.1× 1.5k 3.0× 195 0.4× 320 0.9× 223 6.3k
Wei Xia China 36 297 0.4× 98 0.2× 361 0.7× 42 0.1× 133 0.4× 149 3.6k
Yaodong Zhang China 31 182 0.2× 168 0.3× 489 1.0× 64 0.1× 186 0.5× 211 3.2k
R. Ann Sheldon United States 43 94 0.1× 1.6k 3.2× 1.3k 2.6× 726 1.5× 123 0.4× 97 6.5k
Natalie D. Eddington United States 37 149 0.2× 483 1.0× 123 0.2× 49 0.1× 574 1.7× 122 4.0k

Countries citing papers authored by Limei Zhao

Since Specialization
Citations

This map shows the geographic impact of Limei Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Limei Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Limei Zhao more than expected).

Fields of papers citing papers by Limei Zhao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Limei Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Limei Zhao. The network helps show where Limei Zhao may publish in the future.

Co-authorship network of co-authors of Limei Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Limei Zhao. A scholar is included among the top collaborators of Limei Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Limei Zhao. Limei Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Bai, Rongxian, Limei Zhao, Lei Dai, et al.. (2025). Natural Product-Empowered Green Strategy for Colorimetric Detection of Hydrogen Sulfide. Analytical Chemistry. 97(12). 6473–6480. 2 indexed citations
3.
Zhao, Limei, et al.. (2025). Copper-instigated modulatory cell mortality mechanisms and progress in kidney diseases. Renal Failure. 47(1). 2431142–2431142. 6 indexed citations
4.
Liu, Ran, et al.. (2024). Exploration of the Active Component and Mechanisms of Shengyu Decoction Against Myelosuppression Using Network Pharmacology and in vitro Experimental Validation. Drug Design Development and Therapy. Volume 18. 2405–2420. 2 indexed citations
6.
Zhang, Yujia, et al.. (2024). Population pharmacokinetic analyses of methotrexate in pediatric patients: a systematic review. European Journal of Clinical Pharmacology. 80(7). 965–982. 1 indexed citations
7.
Li, Guofei, et al.. (2024). The role of SIRT1-FXR signaling pathway in valproic acid induced liver injury: a quantitative targeted metabolomic evaluation in epileptic children. Frontiers in Pharmacology. 15. 1477619–1477619. 3 indexed citations
8.
9.
Li, Xinyang, et al.. (2024). An overview of the regulatory role of annexin A1 in the tumor microenvironment and its prospective clinical application (Review). International Journal of Oncology. 64(5). 5 indexed citations
10.
Sun, Haibo, et al.. (2023). Effects of Element Doping on the Structure and Properties of Diamond-like Carbon Films: A Review. Lubricants. 11(4). 186–186. 41 indexed citations
11.
Chen, Jingjing, Liang Huang, Linan Zeng, et al.. (2023). The reference range of lamotrigine in the treatment of epilepsy in children: a systematic review. European Journal of Clinical Pharmacology. 80(1). 1–10. 3 indexed citations
12.
Zhang, Yujia, et al.. (2023). Population pharmacokinetic analyses of tacrolimus in non-transplant patients: a systematic review. European Journal of Clinical Pharmacology. 79(7). 897–913. 5 indexed citations
13.
Zhao, Limei, et al.. (2023). Research progress in nano-drug delivery systems based on the characteristics of the liver cancer microenvironment. Biomedicine & Pharmacotherapy. 170. 116059–116059. 24 indexed citations
14.
Yin, Xiaotong, et al.. (2022). Pharmacokinetic changes for newer antiepileptic drugs and seizure control during pregnancy. CNS Neuroscience & Therapeutics. 28(5). 658–666. 13 indexed citations
15.
Li, Guofei, Mingming Zhao, & Limei Zhao. (2020). Lysine-mediated hydroxyethyl starch-10-hydroxy camptothecin micelles for the treatment of liver cancer. Drug Delivery. 27(1). 519–529. 22 indexed citations
16.
Wang, Yani, et al.. (2020). Involvement of CYP2E1-ROS-CD36/DGAT2 axis in the pathogenesis of VPA-induced hepatic steatosis in vivo and in vitro. Toxicology. 445. 152585–152585. 22 indexed citations
17.
Zhou, Xiaoming, et al.. (2017). Acute pancreatitis induced by tigecycline. 19(2). 132–133. 1 indexed citations
18.
Qiu, Feng, et al.. (2011). Influence of ABCB1, CYP3A4*18B and CYP3A5*3 polymorphisms on cyclosporine A pharmacokinetics in bone marrow transplant recipients. Pharmacological Reports. 63(3). 815–825. 22 indexed citations
19.
Liu, Yongjian, et al.. (2010). Effect of bile acids on growth and body composition of cobia (Rachycentron canadum). Nanfang shuichan. 6(4). 20–25. 9 indexed citations
20.
Zhao, Limei. (2004). Relative bioavailability of effervescent tablet of aspirin-vitamin C in healthy volunteers. Zhōnghuá yàoxué zázhì. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026